VTAK (Catheter Precision) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 24, 2026)


VTAK Catheter Precision Inc VTAK
28 GF Score
Price $1.19
GF Value $1.72
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Catheter Precision Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Catheter Precision's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

VTAK vs VYCO, BJDX, NUWE: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Devices subindustry, Catheter Precision's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Catheter Precision Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Catheter Precision's Margin of Safety % (DCF FCF Based) falls into.


VTAK
28GF Score
Catheter Precision Inc VTAK
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Catheter Precision (VTAK) Overvalued in 2026?

Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued. The current stock price of $1.19 is trading 30.8% below its estimated GF Value™ of $1.72. GuruFocus considers Catheter Precision to be Possible Value Trap.

Key valuation signals for VTAK:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $1.72 vs. price of $1.19 (30.8% below fair value)
  • GF Score™: 28/100 with 7 warning signs

No single metric tells the full story. See the VTAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Catheter Precision Business Description

Address 1670 Highway 160 West, Suite 205, Fort Mill, SC, USA, 29708
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
28GF Score

Get the complete analysis for VTAK

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.19
Price
$1.72
GF Value